Recently Registered Companies Include: Johnson & Johnson, Medtronic, Acadia Pharmaceuticals

The Premier Forum for Senior Biopharma Leaders Looking to Effectively Measure their Patient Engagement Activities

Access the Metrics-First Agenda to Find Out Why Chief Patient Officers & Directors of Patient Engagement Are Clearing Their Calendars This May

From Gaps to Action: Using Disqualification Analysis to Drive Smarter Patient Recruitment

From Gaps to Action: Using Disqualification Analysis to Drive Smarter Patient Recruitment

By | 6 January 2026

Disqualification Analysis is a three-signal intelligence system, not a single metric
Disqualification Analysis can highlight the differences in patient populations versus protocol choices
Disqualification Analysis drives four concrete outcomes: eliminating dead ends, continuous patient engagement, feedback to study teams, and measurable outreach ROI